1-9 of 9
Timothy Devos, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dynamic and Time-to-Event Analyses Demonstrate Marked Reduction in Transfusion Requirements for Janus Kinase Inhibitor-Naïve Myelofibrosis Patients Treated with Momelotinib Compared Head to Head with Ruxolitinib

Ruben A Mesa, MD, John Catalano, MBBS, FRACP, FRCPA, Francisco Cervantes, MD, Timothy Devos, MD PhD, Jason Gotlib, MD MS, Jean-Jacques Kiladjian, MD PhD, Donal P. McLornan, MB, BCh (Hons), MRCP, PhD FRCPath, Kazuya Shimoda, MD PhD, Elisabeth Coart, PhD, Koenraad D'Hollander, MD MSC, Rafe Donahue, PhD, Mark M Kowalski, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1663.
https://doi.org/10.1182/blood-2019-122506
Published: 2019
Journal Articles

Impact of Bone Marrow Fibrosis Grade in Post-Polycythemia Vera and Post-Essential Thrombocythemia Myelofibrosis. a Study of the Mysec Group

Barbara Mora, Elisa Rumi, MD, Paola Guglielmelli, MD PhD, Margherita Maffioli, MD, Daniela Barraco, MD, Alessandro Rambaldi, MD, Marianna Caramella, MD, Rami S. Komrokji, MD, Jason Gotlib, MD MS, Jean-Jacques Kiladjian, MD PhD, Francisco Cervantes, MD, Timothy Devos, MD PhD, Francesca Palandri, PhD MD, Valerio De Stefano, MD, Marco Ruggeri, Richard T. Silver, MD, Giulia Benevolo, MD, Francesco Albano, MD, Chiara Cavalloni, MD, Silvia Uccella, MD, Claudia Siracusa, Tiziano Barbui, MD, Alessandra Iurlo, MD PhD, Lorenza Bertù, Michele Merli, MD, Mario Cazzola, MD, Alessandro M. Vannucchi, MD, Francesco Passamonti, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2946.
https://doi.org/10.1182/blood-2019-124854
Published: 2019
Journal Articles

Real-Life Outcomes of Ponatinib Treatment in Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL): Data from a Nationwide Belgian Registry

Timothy Devos, MD PhD, Violaine Havelange, Koen Theunissen, Stef Meers, Fleur Samantha Benghiat, Alain Gadisseur, Gaëtan Vanstraelen, Marc André, Benjamin Bailly, Nikki Granacher, Philippe Lewalle, Ann De Becker, Koen Van Eygen, Marie Lejeune, Dries Deeren, MD PhD, Gianfilippo Nifosi, Agnes Triffet, Inge Vrelust, Julie Bekaert, Michael Beck, Dominik Selleslag
Journal: Blood
Blood (2019) 134 (Supplement_1): 4161.
https://doi.org/10.1182/blood-2019-127923
Published: 2019
Journal Articles

Preliminary Report of MANIFEST, a Phase 2 Study of CPI-0610, a Bromodomain and Extraterminal Domain Inhibitor (BETi), in Combination with Ruxolitinib, in JAK Inhibitor (JAKi) Treatment Naïve Myelofibrosis Patients

Claire N Harrison, Professor, Andrea Patriarca, MD, John Mascarenhas, MD, Marina Kremyanskaya, Ronald Hoffman, MD, Gary J. Schiller, MD, Brian Leber, MD, Timothy Devos, MD PhD, Sujan Kabir, MD, Adrian Senderowicz, MD, Jennifer Mertz, PhD, Patrick Trojer, PhD, James Shao, MS, Vikas Gupta, MD FRCP, FRCPath
Journal: Blood
Blood (2019) 134 (Supplement_1): 4164.
https://doi.org/10.1182/blood-2019-128211
Published: 2019
Journal Articles

Post-Polycythemia and Post-Thrombocythemia Myelofibrosis Have Distinctive Clinical Phenotypes: An International Multicenter Study on 718 Patients

Domenica Caramazza, MD PhD, Margherita Maffioli, MD, Mario Cazzola, MD, Alessandro Maria Vannucchi, MD, Alessandro Rambaldi, MD, Enrica Morra, Jean-Jacques Kiladjian, MD PhD, Rami S Komrokji, MD, Jason Gotilib, Francisco Cervantes, MD PhD, Paola Guglielmelli, MD PhD, Timothy Devos, MD PhD, Richard T. Silver, MD, Nicola Vianelli, MD, Valerio De Stefano, MD, Marco Ruggeri, MD, Alessandra Ricco, MD, Giulia Benevolo, MD, Barbara Mora, MD, Tiziano Barbui, MD, Lisa Pieri, MDPhD, Cristiana Pascutto, PhD, Elisa Rumi, MD, Francesco Passamonti, MD
Journal: Blood
Blood (2014) 124 (21): 1824.
https://doi.org/10.1182/blood.V124.21.1824.1824
Published: 2014
Journal Articles

A New International Multicenter-Based Model to Predict Survival in Myelofibrosis Secondary to Polycythemia and Thrombocythemia: The Mysec Prognostic Model (MYSEC-PM)

Francesco Passamonti, MD, Vannucchi Alessandro, MD, Caramazza Domenica, MD, Rambaldi Alessandro, MD, Morra Enrica, MD, Kiladjian Jean Jacques, Rami S Komrokji, MD, Margherita Maffioli, MD, Jason Gotlib, MD, Cervantes Francisco, MD PhD, Timothy Devos, MD PhD, Richard T. Silver, MD, Paola Guglielmelli, MD, Nicola Vianelli, MD, Valerio De Stefano, MD, Marco Ruggeri, MD, Giorgina Specchia, MD, Umberto Vitolo, MD, Elisa Rumi, MD, Barbara Mora, MD, Tiziano Barbui, MD, Lisa Pieri, MDPhD, Cristiana Pascutto, PhD, Mario Cazzola, MD
Journal: Blood
Blood (2014) 124 (21): 1826.
https://doi.org/10.1182/blood.V124.21.1826.1826
Published: 2014
Journal Articles

Analysis of Genotype, Phenotype and Outcome in a Belgian Cohort of Essential Thrombocythemia

Carla AL Assaf, Els Lierman, PhD, Florence Van Obbergh, MD, Timothy Devos, MD PhD, Johan Billiet, MD, Carlos Graux, MD PhD, Lucienne Michaux, MD PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5584.
https://doi.org/10.1182/blood.V124.21.5584.5584
Published: 2014
Journal Articles

JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia: A High Resolution SNP Array Study

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Carlos Graux, MD, PhD, Johan Billiet, MD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5258.
https://doi.org/10.1182/blood.V122.21.5258.5258
Published: 2013
Journal Articles

Screening JAK2 V617F-Negative and MPL W515K/L-Negative Essential Thrombocythemia Patients For Mutations In SESN2, DNAJC17, ST13, TOP1MT , and NTRK1

Carla AL Assaf, Els Lierman, PhD, Timothy Devos, MD, PhD, Johan Billiet, MD, Carlos Graux, MD, PhD, Petros Papadopoulos, PhD, Peter Vandenberghe, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5264.
https://doi.org/10.1182/blood.V122.21.5264.5264
Published: 2013